RADICAVA®
RADICAVA® (Edaravone) is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis.
RADICAVA® is manufactured by Mitsubishi Tanabe.
Administration and Dosage:
Administration of RADICAVA® is initially 14 days of intravenous infusion followed by a 14-day drug-free period with subsequent treatment cycles being 10 days out of 14 of intravenous infusion, followed by 14 day drug free periods.
Common Side Effects:
The more common side effects of RADICAVA® include hypersensitivity (allergic) reactions and sulfite allergic reactions.
More information:
Please read the full Prescribing Information and Patient Information for RADICAVA® and discuss any questions you have with your doctor.
Indication:
RADICAVA® is indicated to treat:
Amyotrophic Lateral Sclerosis
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice